Total Payments
$61,889
2024 Payments
$8,047
Companies
16
Transactions
100
Medicare Patients
109
Medicare Billing
$10,468
Payment Breakdown by Category
Other$37,096 (59.9%)
Consulting$10,643 (17.2%)
Research$6,652 (10.7%)
Travel$5,508 (8.9%)
Food & Beverage$1,969 (3.2%)
Education$21.18 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $37,096 | 14 | 59.9% |
| Consulting Fee | $10,643 | 3 | 17.2% |
| Unspecified | $6,652 | 3 | 10.7% |
| Travel and Lodging | $5,508 | 11 | 8.9% |
| Food and Beverage | $1,969 | 68 | 3.2% |
| Education | $21.18 | 1 | 0.0% |
Payments by Type
General
$55,237
97 transactions
Research
$6,652
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $43,432 | 38 | $0 (2024) |
| ABBVIE INC. | $8,808 | 16 | $0 (2022) |
| Astellas Pharma Global Development | $8,805 | 2 | $0 (2023) |
| CooperSurgical, Inc. | $359.68 | 25 | $0 (2024) |
| Hologic, LLC | $124.75 | 4 | $0 (2022) |
| SHIELD THERAPEUTICS INC | $74.82 | 1 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $56.13 | 2 | $0 (2024) |
| Organon LLC | $48.06 | 2 | $0 (2022) |
| MAYNE PHARMA COMMERCIAL LLC | $42.15 | 2 | $0 (2024) |
| DySIS Medical, Inc. | $24.35 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,047 | 17 | Astellas Pharma US Inc ($7,851) |
| 2023 | $37,504 | 39 | Astellas Pharma US Inc ($28,500) |
| 2022 | $7,385 | 19 | Astellas Pharma US Inc ($7,081) |
| 2021 | $2,032 | 12 | AbbVie Inc. ($1,948) |
| 2020 | $6,782 | 10 | AbbVie Inc. ($6,728) |
| 2018 | $116.77 | 2 | AbbVie, Inc. ($100.00) |
| 2017 | $21.18 | 1 | AMAG Pharmaceuticals, Inc. ($21.18) |
All Payment Transactions
100 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Astellas Pharma US Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $585.00 | General |
| 09/10/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $74.82 | General |
| Category: Hematology | ||||||
| 07/18/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Endocrinology | ||||||
| 07/02/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Diagnostics | ||||||
| 05/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Biological | ||||||
| 05/11/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,935.00 | General |
| Category: Biological | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $752.13 | General |
| Category: Biological | ||||||
| 04/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Biological | ||||||
| 04/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $5.59 | General |
| Category: Biological | ||||||
| 03/26/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $22.32 | General |
| 03/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $2.93 | General |
| Category: Biological | ||||||
| 02/27/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: HORMONE THERAPY | ||||||
| 01/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,640.00 | General |
| Category: Biological | ||||||
| 01/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $752.13 | General |
| Category: Biological | ||||||
| 01/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.92 | General |
| Category: Biological | ||||||
| 01/09/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $19.83 | General |
| 12/07/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: Endocrinology | ||||||
| 12/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,520.00 | General |
| Category: Biological | ||||||
| 12/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $752.13 | General |
| Category: Biological | ||||||
| 12/04/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $62.23 | General |
| Category: Biological | ||||||
| 11/29/2023 | Astellas Pharma US Inc | Veozah (Drug) | Travel and Lodging | Cash or cash equivalent | $15.48 | General |
| Category: Biological | ||||||
| 11/01/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: HORMONE THERAPY | ||||||
| 10/28/2023 | CooperSurgical, Inc. | PARAGARD T 380A (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Endocrinology | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,055.00 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 17 | $6,453 | $2,118 |
| 2022 | 2 | 24 | 39 | $10,412 | $4,626 |
| 2021 | 3 | 46 | 46 | $5,297 | $2,509 |
| 2020 | 2 | 27 | 27 | $2,414 | $1,215 |
Total Patients
109
Total Services
129
Medicare Billing
$10,468
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 17 | $6,453 | $2,118 | 32.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 13 | 28 | $8,718 | $4,000 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 11 | $1,694 | $626.30 | 37.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 18 | $2,773 | $1,253 | 45.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 15 | 15 | $1,446 | $699.45 | 48.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 13 | 13 | $1,078 | $555.62 | 51.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 14 | 14 | $1,161 | $619.26 | 53.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 13 | 13 | $1,254 | $595.78 | 47.5% |
About Dr. Teresa Hubka, D.O
Dr. Teresa Hubka, D.O is a Obstetrics & Gynecology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1659354140.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Teresa Hubka, D.O has received a total of $61,889 in payments from pharmaceutical and medical device companies, with $8,047 received in 2024. These payments were reported across 100 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($37,096).
As a Medicare-enrolled provider, Hubka has provided services to 109 Medicare beneficiaries, totaling 129 services with total Medicare billing of $10,468. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics & Gynecology
- Location Chicago, IL
- Active Since 11/29/2005
- Last Updated 11/01/2018
- Taxonomy Code 207V00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1659354140
Products in Payments
- Veozah (Drug) $39,657
- ORILISSA (Drug) $8,542
- Paragard (Device) $196.69
- PARAGARD T 380A (Drug) $131.40
- Lupron (Drug) $100.00
- LO LOESTRIN FE (Drug) $77.68
- ACCRUFER (Drug) $74.82
- MYOSURE TISSUE REMOVAL DEVICE (Device) $71.74
- ORIAHNN (Drug) $64.64
- MYFEMBREE (Drug) $56.13
- JADA SYSTEM (Device) $48.06
- Paragard T 380A (Drug) $31.59
- LILETTA (Drug) $24.43
- DYSIS Ultra (Device) $24.35
- Cologuard Collection Kit (Device) $22.42
- MAKENA (Drug) $21.18
- ACESSA PROVU SYSTEM (Device) $20.82
- APTIMA (Device) $19.15
- Vascepa (Drug) $19.03
- Balcoltra (Drug) $17.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Chicago
Lee Shulman, Md, MD
Obstetrics & Gynecology — Payments: $590,874
Obstetrics & Gynecology $590,874
Maria Teresa Tam, Md, MD
Obstetrics & Gynecology — Payments: $361,281
Obstetrics & Gynecology $361,281
Gregory Ursino, Md, MD
Obstetrics & Gynecology — Payments: $244,410
Obstetrics & Gynecology $244,410
Ayman Al-Hendy
Obstetrics & Gynecology — Payments: $188,089
Obstetrics & Gynecology $188,089
Dr. Julia Geynisman-Tan, Md, MD
Obstetrics & Gynecology — Payments: $75,400
Obstetrics & Gynecology $75,400
Dr. Lemuel Shaffer, M.d, M.D
Obstetrics & Gynecology — Payments: $52,561
Obstetrics & Gynecology $52,561